A systematic review and meta-analysis of cardiovascular disease risk with degarelix and GnRH agonists in prostate cancer. - de Moraes FCA; Sano VKT; Dantas CR; Hoffmeister N; Kelly FA; Burbano RMR (Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2025)